Qidni Labs Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$5M
- Investors
-
25
Qidni Labs General Information
Description
Developer of dialysis technologies and devices designed to make dialysis accessible and sustainable for patients with kidney failure worldwide. The company offers a portable dialysis system that is nearly waterless and battery-powered with cloud-based remote monitoring of treatment and helps remove uremic toxins and other solutes from large volumes of whole blood, enabling patients to remove all barriers in the way patients access treatment.
Contact Information
Website
www.qidni.lifeCorporate Office
- 50 Fountain Plaza
- Suite 1400
- Buffalo, NY 14202
- United States
Corporate Office
- 50 Fountain Plaza
- Suite 1400
- Buffalo, NY 14202
- United States
Qidni Labs Timeline
Qidni Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Later Stage VC (Series A) | 12-Aug-2025 | $5M | Completed | Generating Revenue | ||
| 18. Accelerator/Incubator | 11-Dec-2024 | Completed | Clinical Trials - General | |||
| 17. Accelerator/Incubator | Completed | Clinical Trials - General | ||||
| 16. Accelerator/Incubator | 06-Sep-2024 | Completed | Clinical Trials - General | |||
| 15. Seed Round | 05-Jun-2023 | Completed | Clinical Trials - Phase 1 | |||
| 14. Accelerator/Incubator | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 13. Accelerator/Incubator | 03-Oct-2022 | Completed | Pre-Clinical Trials | |||
| 12. Accelerator/Incubator | 15-Oct-2021 | Completed | Pre-Clinical Trials | |||
| 11. Accelerator/Incubator | $2.63M | Completed | Pre-Clinical Trials | |||
| 10. Accelerator/Incubator | 02-Dec-2020 | $2.63M | Completed | Pre-Clinical Trials |
Qidni Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Qidni Labs Comparisons
Industry
Financing
Details
Qidni Labs Competitors (4)
One of Qidni Labs’s 4 competitors is Vivance, a Venture Capital-Backed company based in Singapore, Singapore.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vivance | Venture Capital-Backed | Singapore, Singapore | ||||
| NextKidney | Venture Capital-Backed | Gorinchem, Netherlands | ||||
| Quanta Dialysis Technologies | Venture Capital-Backed | Warwick, United Kingdom | ||||
| Outset Medical | Formerly VC-backed | San Jose, CA |
Qidni Labs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Qidni Labs Patents
Qidni Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260034283-A1 | Dialysate creation from pre-charged filter | Inactive | 30-Jul-2024 | ||
| US-20260034284-A1 | Dialysate filter | Inactive | 30-Jul-2024 | ||
| US-20260034281-A1 | Electrolyte management of dialysate | Inactive | 30-Jul-2024 | ||
| US-20240216598-A1 | Systems and methods of gas removal from a wearable device | Pending | 27-Aug-2021 | ||
| US-20230355854-A1 | Blood treatment system and methods of controlling same | Pending | 16-Mar-2020 | A61M1/3641 |
Qidni Labs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Qidni Labs Investors (25)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HaloHealth | Angel Group | Minority | ||
| TCA Venture Group | Angel Group | Minority | ||
| Diana (UK) | Accelerator/Incubator | |||
| Communitech | Accelerator/Incubator | Minority | ||
| China Canada Angels Alliance | Angel Group | Minority |
Qidni Labs FAQs
-
When was Qidni Labs founded?
Qidni Labs was founded in 2014.
-
Where is Qidni Labs headquartered?
Qidni Labs is headquartered in Buffalo, NY.
-
What is the size of Qidni Labs?
Qidni Labs has 9 total employees.
-
What industry is Qidni Labs in?
Qidni Labs’s primary industry is Therapeutic Devices.
-
Is Qidni Labs a private or public company?
Qidni Labs is a Private company.
-
What is the current valuation of Qidni Labs?
The current valuation of Qidni Labs is .
-
What is Qidni Labs’s current revenue?
The current revenue for Qidni Labs is .
-
How much funding has Qidni Labs raised over time?
Qidni Labs has raised $8.46M.
-
Who are Qidni Labs’s investors?
HaloHealth, TCA Venture Group, Diana (UK), Communitech, and China Canada Angels Alliance are 5 of 25 investors who have invested in Qidni Labs.
-
Who are Qidni Labs’s competitors?
Vivance, NextKidney, Quanta Dialysis Technologies, and Outset Medical are competitors of Qidni Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
